CAMBRIDGE, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences. Bank of America Merrill Lynch 2013 Health Care Conference Wednesday, May 15, at 4:20 p.m. PT in Las Vegas, NV UBS Global Healthcare Conference Wednesday, May 22, at 11:00 a.m. ET in New York, NY The audio webcast of the presentations will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentations will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation. About Momenta Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel drugs. To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
CONTACT: Lora Pike Momenta Pharmaceuticals, Inc. firstname.lastname@example.org 617.395.5189